U.S. markets close in 1 hour 55 minutes

Koninklijke Philips N.V. (PHG)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
54.47+0.25 (+0.47%)
As of 2:04PM EST. Market open.

Koninklijke Philips N.V.

Philips Center
Amstelplein 2
Amsterdam 1096 BC
31 20 597 7777

IndustryDiagnostics & Research
Full Time Employees80,666

Key Executives

NameTitlePayExercisedYear Born
Mr. François Adrianus van HoutenChairman of Management & CEON/AN/A1960
Ms. Christine Ann PoonIndependent Vice-Chairwoman of the Supervisory Board & Sec.N/AN/A1952
Mr. Abhijit BhattacharyaExec. VP, CFO & Member of the Board of ManagementN/AN/A1961
Mr. Marnix J. van GinnekenExec. VP, Chief Legal Officer & Member of the Board of ManagementN/AN/A1973
Mr. Robert A. CascellaEVP of Strategic Bus. Devel. & Member of Exec. CommitteeN/AN/A1954
Ms. Sophie BechuExec. VP & Chief of OperationsN/AN/A1960
Mr. Kees WesdorpChief Bus. Leader of the Precision Diagnosis Bus.es & Member of Exec. CommitteeN/AN/AN/A
Mr. Leandro MazzoniHead of Investor RelationsN/AN/AN/A
Ms. Daniela SeabrookExec. VP & Chief HR OfficerN/AN/A1973
Mr. Sean CarneyChief Design OfficerN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Koninklijke Philips N.V. operates as a health technology company worldwide. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, and diagnostic X-ray, as well as integrated clinical solutions; interventional X-ray systems, including cardiovascular, radiology and surgery, and interventional imaging and therapy devices; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. The company also offers monitoring and analytics solutions; sleep and respiratory care solutions; emergency care and resuscitation solutions; data, analytics, and actionable workflow products; and connected care informatics solutions. In addition, it provides power toothbrushes; infant feeding and digital parental solutions; male grooming and beauty products; and kitchen appliances, home care, garment care, and coffee products. Further, the company offers digital frameworks that connect consumers, patients, healthcare providers, payers, and partners in a cloud-based connected health ecosystem of solutions, products, systems, services, and devices. It has a strategic collaboration with BioIntelliSense to integrate BioSticker medical device into the company's remote patient monitoring offering to help monitor at-risk patients from the hospital into the home; a collaboration with Singapore General Hospital to establish the digital and computational pathology center of excellence; and partnership with InSightec. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Corporate Governance

Koninklijke Philips N.V.’s ISS Governance QualityScore as of December 1, 2020 is 2. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 7; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.